Head-to-head · WeighScore
Claya vs Ravia Health
The verdict
Claya takes it — 62.8/100 to 59.2/100.
Claya grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Claya | Ravia Health |
|---|---|---|
| WeighScore | 62.8/100 | 59.2/100 |
| Grade | C | C |
| Scorecard rank | #267 | #347 |
| Semaglutide | $299/mo (compounded) | Not disclosed |
| Tirzepatide | $299/mo (compounded) | Not disclosed |
| Coverage | Coverage not published | 1 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Yes | Injection only |
Graded #267 · C
Strengths
- Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
- Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
- Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
- Weight-loss money-back guarantee published on the homepage
- Free expedited shipping included in the monthly price
Where it loses points
- States-served list not disclosed — you must check at checkout
- LegitScript certification status not displayed
- Corporate legal entity not disclosed on the site or privacy policy
- Oral compounded tablets have weaker efficacy data than injectable semaglutide
- Intro pricing is higher at refill ($299), erasing the first-month advantage
Graded #347 · C
Strengths
- Integrative psychiatry model combines GLP-1 weight-loss with mental health and metabolic care under one board-certified NP provider
- Founded by Dr. Raashida Portier (DNP, PMHNP-BC, FNP-BC); named clinician with dual board certifications in psychiatry and family medicine
- Membership-supported ongoing care from $49/month provides medication management structure with consistent follow-up
- Labs and metabolic workup available as part of integrative psychiatry model; lab testing noted in weight-loss program
- Weight-loss page claims nationwide availability via Lyv Health partnership for eligible patients
Where it loses points
- GLP-1 medication pricing fully gated — not disclosed until consultation; compounded vs. brand status unclear on public pages
- Primarily a psychiatric practice — weight loss is a secondary service, not the core offering or brand identity
- Core services explicitly Florida-only; nationwide weight-loss claim relies on Lyv Health partnership with unverified state coverage
- No LegitScript certification or third-party accreditation found on public pages
- Small single-provider practice with no published outcomes data or external reviews available
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.